Skip to content

APOTHEEK VERSE

Active
Private limited companyfounded 2007active for 18 yearsMarnixlaan 16, 1000 Brussel, BelgiumKBO/BCE: BE 0893.942.595
Summary

APOTHEEK VERSE has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€64,381) and a net result of -€5,699. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 5% of 12,777 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.9% (low).

Overview

Official details

Source: KBO
Status
Active since 05-12-2007 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.167.005.140 1000 Brussel, since 01-01-2008
Financial year end
31 December
Peppol
Reachable

Financial position

53 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.9%
Annual accounts 2025
Gross margin
€6,020
Turnover
≈ €64,000
estimated
Loss
€5,699
▼ 82.8%
Equity
-€64,381
▼ 9.7%
Total assets
€98,336
▼ 9.1%
  • Negative equity on 31-12-2025
  • 2025 accounts filed 13 days after the deadline
Score breakdownraises riskCapped at 59: negative equityNegative equity -€64,381Loss of €5,699, the second in a row (financial year 2025)lowers riskSize: total assets €98,336Founded in 2007Show the evidence

Checked score

Score 2025
53 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 17% of micro companies in retail trade (NACE 47)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Weak
Solvency 0=
equity -65.5% of total assets
Liquidity 17+13
short-term debt 137.9% · cash 13.7%
Profitability 16+16
return on assets -5.8%
Bankruptcy probability within 12 months
0.9% Low
0%0.5%1.5%4%10%≥ 25%

About 9 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,281 companies, NACE 47, micro)
Last 24 months 12-2024: 1.5% 01-2025: 1.5%● unchanged vs 12-2024 02-2025: 1.5%● unchanged vs 01-2025 03-2025: 1.5%● unchanged vs 02-2025 04-2025: 1.6%▲ +0.1 percentage points vs 03-2025 05-2025: 1.5%▼ -0.1 percentage points vs 04-2025 06-2025: 1.5%● unchanged vs 05-2025 07-2025: 1.7%▲ +0.2 percentage points vs 06-2025 08-2025: 1.7%● unchanged vs 07-2025 09-2025: 1.7%● unchanged vs 08-2025 10-2025: 1.7%● unchanged vs 09-2025 11-2025: 1.7%● unchanged vs 10-2025 12-2025: 1.7%● unchanged vs 11-2025 01-2026: 1.7%● unchanged vs 12-2025 02-2026: 1.7%● unchanged vs 01-2026 03-2026: 1.6%▼ -0.1 percentage points vs 02-2026 04-2026: 1.6%● unchanged vs 03-2026 05-2026: 1.6%● unchanged vs 04-2026 06-2026: 1.6%● unchanged vs 05-2026 07-2026: 1.6%● unchanged vs 06-2026 08-2026: 2.2%▲ +0.6 percentage points vs 07-2026highest value 09-2026: 0.9%▼ -1.3 percentage points vs 08-2026 10-2026: 0.9%● unchanged vs 09-2026lowest value 11-2026: 0.9%● unchanged vs 10-2026lowest value
No credit on open account
Liquidity is insufficient, with a current ratio of 0.7 (0.62 in 2024), below 1. Short-term debt is 137.9% and cash 13.7% of total assets. Equity is negative.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 6% of them on solvency, 16% on liquidity, 20% on profitability and 26% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €98,336
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Negative equity -€64,381
NBB · annual accounts
lowers risk · Founded in 2007
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Loss of €5,699, the second in a row (financial year 2025)
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year -€64,381
neutral · A punctual record breaks
This company filed 3 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-08-2026, 13 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filings
Deviation from the deadline
2025
13 days late
2024
21 days early
2023
30 days early
2022
60 days early
2021
8 days late
2020
33 days early
2019
42 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 24 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 July (4 of the last 5 accounts filed within 34 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Risk: Negative equitydebts exceed assets in financial year 2025 -€64,381 View
  • Risk: 3 loss-making years in a rowloss in financial year 2025 -€5,699 View
  • Caution: Lower solvency than 95% of companies in retail tradesector median 36.6% · 12,777 companies -65.5% View

Recent changes

  1. · Gazette deed Change of role: VERSé Yolande Jeannine Josephine Nelly, from manager to director
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as APOTHEEK VERSE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €73,400 and €175,000, founded between 1995 and 2010.

CompanyTotal assetsGross margin
APOTHEEK VERSE Brussel€98,336€6,020
GOED TER LEY Sint-Laureins€95,515€5,055
BOVISEL Tielt€73,406€7,836
Apotheek Stockman Zelzate€79,309€9,633
Apotheek Spaanse Kroon Leuven€110,316€4,464
Pharmacie VERHEYDEN Brussel€135,673€6,854
APOTHEEK VUNCKX-PEETERS Anderlecht€175,073€5,701
Full comparison

Key facts about APOTHEEK VERSE

What is the company number of APOTHEEK VERSE?
The company number of APOTHEEK VERSE is 0893.942.595. The VAT number is the same number with BE in front: BE 0893.942.595.
Where is APOTHEEK VERSE based?
The registered office is at Marnixlaan 16, 1000 Brussel.Company details
What does APOTHEEK VERSE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK VERSE?
The legal form of APOTHEEK VERSE is Private limited company (BV).
When was APOTHEEK VERSE founded?
APOTHEEK VERSE was founded on 05-12-2007.
Is APOTHEEK VERSE still active?
Yes, APOTHEEK VERSE is an active enterprise in the KBO register.
What is the turnover of APOTHEEK VERSE?
The turnover in financial year 2025 is ≈ €64,000. This figure is estimated from the gross margin of €6,020 and 49 comparable companies (NACE 477). It probably lies between €32,000 and €160,000. It is a rough estimate.Financials
Is APOTHEEK VERSE profitable?
In financial year 2025, APOTHEEK VERSE made a loss of €5,699.
Where can I find the annual accounts of APOTHEEK VERSE?
APOTHEEK VERSE filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK VERSE due?
APOTHEEK VERSE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.